Harvest Healthcare Leaders Income ETF (HHL.TO) ETF Analysis

Fund Overview

Harvest Healthcare Leaders Income ETF (HHL.TO) is an exchange-traded fund. The fund is issued by Harvest Portfolios Group Inc. It has been trading since February 6, 2017.

Its biggest positions are Regeneron Pharmaceuticals Inc (REGN), Boston Scientific Corp (BSX), and Bristol-Myers Squibb Co (BMY). Regeneron Pharmaceuticals Inc alone accounts for 5.34% of the portfolio. The ten largest positions together make up 50.34% of the fund.

Performance Analysis

The most recent close on file for HHL.TO is CA$7.47, dated September 4, 2026. The trailing one-year price return is +12.77%. Measured over 5 years, that is +5.79% a year compounded. The fund distributes at a trailing yield of 9.96%.

2026 is still running; the price is +2.98% year to date. The strongest complete calendar year on file is 2021 at +23.91%; the weakest is 2022 at +1.24%. Of the 7 complete calendar years on file, 7 finished higher.

Price & Risk Profile

Daily returns over the trailing 8 years annualize to a volatility of 16.75%. The reported beta is 0.95. Over the past 52 weeks the price has ranged from CA$6.67 to CA$7.99. The latest close sits 11.99% above that 52-week low. The volatility figure is calculated from the stored daily closes, the same series the charts on this page use.